✦ LIBER ✦

Etravirine useful for NNRTI- and PI-resistant HIV-1 infections

Book ID: 120846640
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 121 KB
Volume: 1586
Category: Article
ISSN: 1173-8324
DOI: 10.1007/BF03272607

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etravirine approved in US for treatment-

Etravirine approved in US for treatment-resistant HIV infections

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

PIN58 COST-EFFECTIVENESS OF ETRAVIRINE I

PIN58 COST-EFFECTIVENESS OF ETRAVIRINE IN SWEDEN IN TREATMENT-EXPERIENCED HIV-I-INFECTED ADULTS WITH EVIDENCE OF NNRTI RESISTANCE AND AT LEAST 3 PI MUTATIONS

✍ Moeremans, K; Hjelmgren, J; Martin, SO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Follow-up of a multi-drug resistant HIV-

Follow-up of a multi-drug resistant HIV-1 infected patient successfully treated with darunavir and etravirine

✍ Anne Margrethe Audelin; Anne-Mette Lebech; Ann Berith Petersen; Louise Bruun Jør 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

## Abstract A multi‐drug‐resistant, non‐compliant HIV‐1 patient was treated successfully with a combination of the drugs darunavir and etravirine for more than 8 months. The patient experienced an immunoreconstitution syndrome due to improved compliance. Examining previous resistance tests for this

Increasing Rate of TAMs and Etravirine R

Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment

✍ Messou, Eugène; Chaix, Marie-Laure; Gabillard, Delphine; Yapo, Vincent; Toni, Th 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 154 KB

Etravirine in treatment-experienced, HIV

Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

✍ Tudor-Williams, G; Cahn, P; Chokephaibulkit, K; Fourie, J; Karatzios, C; Dincq, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

ChemInform Abstract: Non-Nucleoside Reve

ChemInform Abstract: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections: Strategies to Overcome Drug Resistance Development

✍ E. DE CLERCQ 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB